Network origin in An Song first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 20 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to An Song via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Ignite Immunotherapy, Inc.
 Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Part of Pfizer Inc., Ignite Immunotherapy, Inc. is a company that designs and develops oncolytic virus vaccines. The company is based in New York, NY. The company was founded by David Schaffer, Douglas Hanahan, David H. Kirn, Theresa Janke, Melissa Kotterman. The CEO is Monika A. Vnuk. | Biotechnology | Founder Founder Founder Founder | |
| University of California, Berkeley | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Corporate Officer/Principal | |
| University of Oxford | College/University | Corporate Officer/Principal Graduate Degree | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Founder Chief Tech/Sci/R&D Officer | |
| INTERMUNE INC | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ALEXZA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Berkeley Frontier Fund
 Berkeley Frontier Fund Investment ManagersFinance Berkeley Frontier Fund (Berkeley Frontier Fund) is a venture capital firm founded in 202. The firm is headquartered in Berkeley, California. | Investment Managers | Consultant / Advisor Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| CELGENE | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| American Society of Gene Therapy | Director/Board Member | ||
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
| UNIQURE N.V. | Biotechnology | Director/Board Member | |
| Moravian College | College/University | Undergraduate Degree | |
| CABALETTA BIO, INC. | Biotechnology | Director/Board Member | |
| Society for Biological Engineering | Director/Board Member | ||
| ALLOVIR, INC. | Biotechnology | Director/Board Member | |
| TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree | |
| The Berkley Stem Cell Center | Director/Board Member | ||
| GILEAD SCIENCES, INC. | Biotechnology | Chief Executive Officer | |
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Chairman | |
| DIPLOMAT PHARMACY, INC. | Drugstore Chains | Director/Board Member | |
| University College London | College/University | Doctorate Degree | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Cincinnati (Ohio) | College/University | Undergraduate Degree | |
| Murray State University (Kentucky) | College/University | Masters Business Admin | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| KITE PHARMA INC | Biotechnology | Corporate Officer/Principal | |
| University of California | College/University | Corporate Officer/Principal | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Shawn Tomasello Consulting LLC
 Shawn Tomasello Consulting LLC Miscellaneous Commercial ServicesCommercial Services Shawn Tomasello Consulting LLC provides business consulting services. The private company is based in Miramar Beach. The American company was founded by Shawn Cline Tomasello. | Miscellaneous Commercial Services | Chief Executive Officer | |
| CENTREXION THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| UROGEN PHARMA LTD. | Biotechnology | Director/Board Member | |
| MESOBLAST LIMITED | Biotechnology | Director/Board Member | |
Geneos Therapeutics, Inc.
 Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Biotechnology | Director/Board Member | |
Axent Biosciences, Inc.
 Axent Biosciences, Inc. BiotechnologyHealth Technology Axent Biosciences, Inc. engages as a biotechnology company. It develops stem cell therapies to address unmet medical needs in human diseases and disorders. The company is headquartered in Oakland, CA. | Biotechnology | Founder | |
Valitor, Inc.
 Valitor, Inc. BiotechnologyHealth Technology Valitor, Inc. develops a new generation of biotechnology drugs. It develops methods of modifying therapeutic proteins to achieve substantial control over pharmacokinetics, target specificity and bioactivity. The company was founded by Kevin E. Healy, Wesley M. Jackson and David Schaffer in 2010 and is headquartered in Berkeley, CA. | Biotechnology | Founder | |
| International Institute for Management Development | College/University | Masters Business Admin | |
| JUNO THERAPEUTICS INC | Biotechnology | Corporate Officer/Principal | |
| San Jose State University | College/University | Undergraduate Degree | |
| American University | College/University | Doctorate Degree | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director of Finance/CFO | |
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Medical Specialties | Director of Finance/CFO |
Statistics
International
| United States | 42 |
| United Kingdom | 5 |
| Netherlands | 2 |
| Israel | 2 |
| Canada | 2 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 15 |
| Commercial Services | 4 |
| Finance | 3 |
| Retail Trade | 2 |
Operational
| Director/Board Member | 66 |
| Corporate Officer/Principal | 36 |
| Independent Dir/Board Member | 28 |
| Chief Tech/Sci/R&D Officer | 19 |
| Undergraduate Degree | 17 |
Most connected contacts
| Insiders | |
|---|---|
| Shawn Tomasello | 22 |
| Susannah Gray | 20 |
| Jacob Chacko | 18 |
| David Schaffer | 15 |
| Nancy Miller-Rich | 15 |
| David Kirn | 13 |
| Robert Fishman | 11 |
| August Moretti | 10 |
| John Milligan | 9 |
| Charles Theuer | 9 |
| Uneek Mehra | 8 |
| Theresa Janke | 6 |
| Fariborz Kamal | 6 |
| Scott Bizily | 6 |
| Peter Francis | 5 |
- Stock Market
- Insiders
- An Song
- Company connections
